• Kaja Kallas
  • Moussa Faki Mahamat
  • Adrian Zenz
  • Matthew Kroenig
  • Andriy Yermak
  • Vitaly Savelyev
  • Oleksandr Korniyenko
  • Dainius Kreivys
View All
IPSE'S AUTHORS LAST 24h
Check all the Authors in the last 24h
IPSEs IN THE LAST 24H
  • Alon Liel
    Alon Liel “The move [Egypt joining South Africa's ICJ genocide case against Israel] is an unbelievable diplomatic blow to Israel. Egypt is the cornerstone of our standing in the Middle East. The connections that Israel has in the Middle East and North Africa today, including with Jordan, the UAE and Morocco, is all a result of what Egypt did 40 years ago. With Egypt joining South Africa now in The Hague, it's a real diplomatic punch. Israel would have to take it very seriously. This is what I have been warning about. It's coming from several directions. Israel has to … listen to the world - not only to the Israeli public opinion asking now for revenge. We have to look overall in the wider picture, in the long-term security of Israel, not only in the next few weeks in Gaza.” 12 hours ago
  • Franz-Stefan Gady
    Franz-Stefan Gady “The Russians have understood, just as a lot of analysts have, that the major disadvantage that Ukraine is currently suffering from is manpower. By thinning out the frontline, you are increasing the odds of a breakthrough.” 14 hours ago
  • Oleksandr Syrskyi
    Oleksandr Syrskyi “This week, the situation in Kharkiv Oblast deteriorated substantially. Currently, there are continuing battles along the state's border with Russia. The situation is challenging, but the Defence Forces are doing everything possible to maintain defensive lines and positions, resulting in defeat for the adversary.” 15 hours ago
  • John Kirby
    John Kirby “It is possible that Russia will make further advances in the coming weeks, but we do not anticipate any major breakthroughs, and over time, the influx of U.S. assistance will enable Ukraine to withstand these attacks over the course of 2024.” 15 hours ago
  • Volker Türk
    Volker Türk “I can see no way that the latest evacuation orders, much less a full assault, in an area with an extremely dense presence of civilians, can be reconciled with the binding requirements of international humanitarian law and with the two sets of binding provisional measures ordered by the International Court of Justice.” 15 hours ago
View All IPSEs inserted in the Last 24h

#BioNTech

Page with all the IPSEs stored in the archive with the tag #BioNTech linked to them.
The IPSEs are presented in chronological order based on when the IPSEs have been pronounced.

Ursula von der Leyen
Ursula von der Leyen

“Included in our plans are also the questions of how reliable the partners, how much a partner has proven that he can deliver, and this is exactly what BioNTech/Pfizer has done. We went through initial difficulties, and the experience of overcoming together difficulties, working hard together and sticking together ... was a very good experience that builds trust. On this trust, I think we can also build the future.”

author
President of the European Commission
23 Apr 2021 5 4
Read More
Steven Hahn
Steven Hahn

“Americans want us to do a scientific review, but I think they also want us to make sure we’re not wasting time on paperwork as opposed to going forward with the decision.”

author
U.S. Food and Drug Administration Commissioner
10 Dec 2020 8 3
Read More
Steven Hahn
Steven Hahn

“We’re working very closely with our UK partners to understand what went on with respect to those allergic reactions. FDA is the gold standard for regulatory approval or authorization of medical products. If our career scientists say that the vaccine is safe and effective, I have complete confidence in that decision, and I think the American people should as well.”

author
U.S. Food and Drug Administration Commissioner
10 Dec 2020 6 4
Read More
Supriya Sharma
Supriya Sharma

“Canadians can have confidence ... the vaccine was authorized only after a thorough assessment of the evidence demonstrated it had met Health Canada's strict standards for efficacy, safety and quality. It's an exceptional day for Canada. In a year when we haven't had a lot of good news, this is a bit of good news and we should acknowledge that. We are always on the lookout for more serious adverse events. It is still a vaccine and there are potential risks even if they are rare. That's why it's important that we still continue to monitor it. Because these vaccines will be used in otherwise healthy people ... our tolerance for safety issues is very, very low.”

Cbc

author
Chief medical adviser to Health Canada's deputy minister
09 Dec 2020 7 2
Read More
Cole Pinnow
Cole Pinnow

“This is historic. We couldn't be more proud that Pfizer and BioNTech were able to bring to Canada the first COVID-19 vaccine. We think this represents a monumental change in the way that we are fighting the pandemic, and hopefully represents the first big step towards normalcy. I would reassure Canadians that the scientific rigour and regulatory oversight that went into this product is as robust, if not more robust, than any other vaccine that's been brought to market.”

Cbc

author
President of Pfizer Canada
09 Dec 2020 6 2
Read More
Sean Marett
Sean Marett

“If I use the U.K. as an example, we got approval at 1:00 am in the morning. We approved [the] release of the vaccine and shipped it within 24 hours. Certainly from the discussions that we've had, Canada is in a good position to approve the vaccine shortly. Upon approval, we then release the vaccine and then it is shipped. We've already produced the vaccine and reserved doses for Canada.”

Cbc

author
Chief business and chief commercial officer of Germany's BioNTech
06 Dec 2020 6 4
Read More
IPSEs by Context
May
MonTueWedThuFriSatSun
0102030405
06070809101112
13141516171819
20212223242526
2728293031
IPSEs by City
IPSEs by Author
IPSEs by Entity
IPSEs by Country
arrow